100 related articles for article (PubMed ID: 21900455)
1. Decoy receptor 3 inhibits renal mononuclear leukocyte infiltration and apoptosis and prevents progression of IgA nephropathy in mice.
Ka SM; Hsieh TT; Lin SH; Yang SS; Wu CC; Sytwu HK; Chen A
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1218-30. PubMed ID: 21900455
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
[TBL] [Abstract][Full Text] [Related]
3. Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome.
Yang SM; Ka SM; Hua KF; Wu TH; Chuang YP; Lin YW; Yang FL; Wu SH; Yang SS; Lin SH; Chang JM; Chen A
Free Radic Biol Med; 2013 Aug; 61():285-97. PubMed ID: 23567192
[TBL] [Abstract][Full Text] [Related]
4. In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions.
Tam KY; Leung JC; Chan LY; Lam MF; Tang SC; Lai KN
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F359-68. PubMed ID: 20484297
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
6. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.
Hua KF; Yang SM; Kao TY; Chang JM; Chen HL; Tsai YJ; Chen A; Yang SS; Chao LK; Ka SM
PLoS One; 2013; 8(10):e77794. PubMed ID: 24204969
[TBL] [Abstract][Full Text] [Related]
7. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
[TBL] [Abstract][Full Text] [Related]
11. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.
Kanamaru Y; Arcos-Fajardo M; Moura IC; Tsuge T; Cohen H; Essig M; Vrtovsnik F; Loirat C; Peuchmaur M; Beaudoin L; Launay P; Lehuen A; Blank U; Monteiro RC
Eur J Immunol; 2007 Apr; 37(4):1116-28. PubMed ID: 17393381
[TBL] [Abstract][Full Text] [Related]
12. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
Lin TJ; Yang SS; Hua KF; Tsai YL; Lin SH; Ka SM
Free Radic Biol Med; 2016 Oct; 99():214-224. PubMed ID: 27519267
[TBL] [Abstract][Full Text] [Related]
13. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
14. Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy.
Montinaro V; Aventaggiato L; Cavallo T; Rifai A
Nephrol Dial Transplant; 1995 Nov; 10(11):2035-42. PubMed ID: 8643164
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure.
Chan LY; Leung JC; Lai KN
Clin Exp Nephrol; 2004 Dec; 8(4):297-303. PubMed ID: 15619027
[TBL] [Abstract][Full Text] [Related]
16. Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases.
Weng SC; Tarng DC
J Chin Med Assoc; 2019 Sep; 82(9):680-684. PubMed ID: 31356560
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
[TBL] [Abstract][Full Text] [Related]
18. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
19. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.
Goto T; Bandoh N; Yoshizaki T; Nozawa H; Takahara M; Ueda S; Hayashi T; Harabuchi Y
Clin Immunol; 2008 Mar; 126(3):260-9. PubMed ID: 18249037
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte infiltration and intercellular adhesion molecule-1-mediated cell interactions in immunoglobulin A nephropathy.
Arrizabalaga P; Solé M; Quintó L; Ascaso C; Engel P
Arch Pathol Lab Med; 1998 Sep; 122(9):817-22. PubMed ID: 9740142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
